IKBKB
Inhibitor of nuclear factor kappa-B kinase subunit beta
Also known as: IKK-beta, IKK2, IKKB, IKKB_HUMAN, NFKBIKB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14920
- Gene
- IKBKB
- Ensembl
- ENSG00000104365
- Chromosome
- 8
- Canonical length
- 756 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene phosphorylates the inhibitor in the inhibitor/NF-kappa-B complex, causing dissociation of the inhibitor and activation of NF-kappa-B. The encoded protein itself is found in a complex of proteins. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
756 residues, UniProt reviewed canonical sequence.
>O14920|IKBKB
1 MSWSPSLTTQ TCGAWEMKER LGTGGFGNVI RWHNQETGEQ IAIKQCRQEL SPRNRERWCL
61 EIQIMRRLTH PNVVAARDVP EGMQNLAPND LPLLAMEYCQ GGDLRKYLNQ FENCCGLREG
121 AILTLLSDIA SALRYLHENR IIHRDLKPEN IVLQQGEQRL IHKIIDLGYA KELDQGSLCT
181 SFVGTLQYLA PELLEQQKYT VTVDYWSFGT LAFECITGFR PFLPNWQPVQ WHSKVRQKSE
241 VDIVVSEDLN GTVKFSSSLP YPNNLNSVLA ERLEKWLQLM LMWHPRQRGT DPTYGPNGCF
301 KALDDILNLK LVHILNMVTG TIHTYPVTED ESLQSLKARI QQDTGIPEED QELLQEAGLA
361 LIPDKPATQC ISDGKLNEGH TLDMDLVFLF DNSKITYETQ ISPRPQPESV SCILQEPKRN
421 LAFFQLRKVW GQVWHSIQTL KEDCNRLQQG QRAAMMNLLR NNSCLSKMKN SMASMSQQLK
481 AKLDFFKTSI QIDLEKYSEQ TEFGITSDKL LLAWREMEQA VELCGRENEV KLLVERMMAL
541 QTDIVDLQRS PMGRKQGGTL DDLEEQAREL YRRLREKPRD QRTEGDSQEM VRLLLQAIQS
601 FEKKVRVIYT QLSKTVVCKQ KALELLPKVE EVVSLMNEDE KTVVRLQEKR QKELWNLLKI
661 ACSKVRGPVS GSPDSMNASR LSQPGQLMSQ PSTASNSLPE PAKKSEELVA EAHNLCTLLE
721 NAIQDTVREQ DQSFTALDWS WLQTEEEEHS CLEQASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IKBKB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- tongue: 23 nTPM
- spleen: 16 nTPM
- skeletal muscle: 15 nTPM
- esophagus: 15 nTPM
- adrenal gland: 13 nTPM
- parathyroid gland: 13 nTPM
Single-cell type
- myonuclei: 153 nCPM
- neutrophils: 145 nCPM
- cone photoreceptor cells: 143 nCPM
- microglia: 137 nCPM
- papillary tip epithelial cells: 106 nCPM
- prostatic hillock cells: 105 nCPM
Immune cell
- plasmacytoid DC: 8.5 nTPM
- basophil: 7.5 nTPM
- T-reg: 5.9 nTPM
- eosinophil: 5.7 nTPM
- non-classical monocyte: 5.6 nTPM
- memory CD8 T-cell: 5.5 nTPM
Brain region
- choroid plexus: 12 nTPM
- medulla oblongata: 9.6 nTPM
- thalamus: 8.7 nTPM
- white matter: 8.5 nTPM
- midbrain: 8.1 nTPM
- pons: 8.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IKBKB.
Disease | AllUniProt
Conditions IKBKB is implicated in, by any mechanism.
- Immunodeficiency 15B (IMD15B) MIM:615592
- Immunodeficiency 15A (IMD15A) MIM:618204
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 859 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Severe combined immunodeficiency due to IKK2 deficiency
- IKBKB-related disorder
- Immunodeficiency 15a
- Severe combined immunodeficiency disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.59
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
- autophagy
- canonical NF-kappaB signal transduction
- cellular response to tumor necrosis factor
- Fc-epsilon receptor signaling pathway
- inflammatory response
- innate immune response
- integrin-mediated signaling pathway
- interleukin-1-mediated signaling pathway
- MyD88-dependent toll-like receptor signaling pathway
- negative regulation of autophagy
- negative regulation of bicellular tight junction assembly
- negative regulation of cytokine production involved in inflammatory response
- peptidyl-serine phosphorylation
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of DNA-templated transcription
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of transcription by RNA polymerase II
- protein localization to plasma membrane
- protein maturation
- protein phosphorylation
- regulation of establishment of endothelial barrier
- regulation of toll-like receptor signaling pathway
- regulation of tumor necrosis factor-mediated signaling pathway
- response to virus
- stimulatory C-type lectin receptor signaling pathway
- stress-activated MAPK cascade
- T cell receptor signaling pathway
- toll-like receptor 3 signaling pathway
- TRIF-dependent toll-like receptor signaling pathway
- tumor necrosis factor-mediated signaling pathway
Molecular functions
- ATP binding
- identical protein binding
- IkappaB kinase activity
- protein heterodimerization activity
- protein homodimerization activity
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- scaffold protein binding
- transferrin receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin-like domain
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- I-kappa-kinase-beta NEMO binding domain
- Ubiquitin-like domain superfamily
- IKBKB, scaffold dimerization domain
- IKBKB, scaffold dimerization domain superfamily
- Inhibitor of nuclear factor kappa-B kinase
- Protein kinase domain
- I-kappa-kinase-beta NEMO binding domain
- IQBAL scaffold dimerization domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IKBKB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IKBKB as an antibody target. Whether an autoantibody or antibody against IKBKB could matter depends on whether native IKBKB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IKBKB is annotated at the cell surface, where native IKBKB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IKBKB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...